Bio-Rad Laboratories, Inc.
Updates & Highlights
MarketBeat · about 8 hours ago
Assenagon Asset Management S.A. Acquires 85,393 Shares of Bio-Rad Laboratories, Inc. $BIO
MarketBeat · 2 days ago
Bio-Rad Laboratories, Inc. $BIO Shares Bought by California State Teachers Retirement System
Yahoo Finance · 3 days ago
Bio-Rad Laboratories, Inc. Q2 2026 Earnings Call Summary
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Parental Leave
Family-friendly policies
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Bio-Rad Laboratories, Inc.?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentAssenagon Asset Management S.A. Acquires 85,393 Shares of Bio-Rad Laboratories, Inc. $BIO
Assenagon Asset Management S.A. Acquires 85,393 Shares of Bio-Rad Laboratories, Inc. $BIO
MarketBeat · about 8 hours ago
Bio-Rad Laboratories, Inc. $BIO Shares Bought by California State Teachers Retirement System
Bio-Rad Laboratories, Inc. $BIO Shares Bought by California State Teachers Retirement System
MarketBeat · 2 days ago
Bio-Rad Laboratories, Inc. Q2 2026 Earnings Call Summary
Bio-Rad Laboratories, Inc. Q2 2026 Earnings Call Summary
Yahoo Finance · 3 days ago
Amundi Has $10.81 Million Holdings in Bio-Rad Laboratories, Inc. $BIO
Amundi Has $10.81 Million Holdings in Bio-Rad Laboratories, Inc. $BIO
MarketBeat · 3 days ago
Bio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary
Bio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary
TradingView · 4 days ago
Bio-Rad Laboratories, Inc. (BIO) Q2 FY2026 earnings call transcript
Bio-Rad Laboratories, Inc. (BIO) Q2 FY2026 earnings call transcript
Yahoo Finance · 4 days ago
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q2 Revenue $651.0M, vs. FactSet Est of $624.0M
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q2 Revenue $651.0M, vs. FactSet Est of $624.0M
marketscreener.com · 4 days ago
BIO-RAD LABORATORIES, INC. 2Q 2026: Revenue $651M, EPS $13.85— 10-Q Summary
BIO-RAD LABORATORIES, INC. 2Q 2026: Revenue $651M, EPS $13.85— 10-Q Summary
TradingView · 4 days ago
Arrowstreet Capital Limited Partnership Invests $4.39 Million in Bio-Rad Laboratories, Inc. $BIO
Arrowstreet Capital Limited Partnership Invests $4.39 Million in Bio-Rad Laboratories, Inc. $BIO
MarketBeat · 4 days ago
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 8.75% Potential Downside Amidst Strong Sector Position
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 8.75% Potential Downside Amidst Strong Sector Position
DirectorsTalk Interviews · 5 days ago
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Evaluating Growth Amidst Stable Price Movements
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Evaluating Growth Amidst Stable Price Movements
DirectorsTalk Interviews · about 1 month ago
Bio-Rad Laboratories, Inc. Class B Actuals & Estimates (FWB:BUW)
Bio-Rad Laboratories, Inc. Class B Actuals & Estimates (FWB:BUW)
TradingView · about 1 month ago
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Tight Market with Strategic Growth Potential
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Tight Market with Strategic Growth Potential
DirectorsTalk Interviews · 2 months ago
Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching
Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching
富途牛牛 · 2 months ago
[144] BIO-RAD LABORATORIES, INC. SEC Filing
[144] BIO-RAD LABORATORIES, INC. SEC Filing
Stock Titan · 2 months ago
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Medical Device Terrain with a 3.22% Upside
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Medical Device Terrain with a 3.22% Upside
DirectorsTalk Interviews · 3 months ago
Bio-Rad Laboratories, Inc. Class B Trade Ideas — BOATS:BIO.B
Bio-Rad Laboratories, Inc. Class B Trade Ideas — BOATS:BIO.B
TradingView · 3 months ago
Bio-Rad Laboratories, Inc. Class B Trade Ideas — LS:862449
Bio-Rad Laboratories, Inc. Class B Trade Ideas — LS:862449
TradingView · 3 months ago
Number of shareholders of Bio-Rad Laboratories, Inc. – NYSE:BIO
Number of shareholders of Bio-Rad Laboratories, Inc. – NYSE:BIO
TradingView · 3 months ago
Number of shareholders of Bio-Rad Laboratories, Inc. Class B – LS:862449
Number of shareholders of Bio-Rad Laboratories, Inc. Class B – LS:862449
TradingView · 3 months ago